Phase II study of antineoplaston A10 in patients with primary liver cancer
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2017
At a glance
- Drugs Antineoplaston-A10 (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 19 Nov 2017 Status changed from active, no longer recruiting to discontinued.
- 19 Sep 2005 New trial record.